Zavation Medical Products, LLC has acquired ChoiceSpine LLC for an undisclosed amount, marking a significant corporate acquisition within the medical device industry. This transaction sees Zavation taking full ownership of ChoiceSpine, a company dedicated to bringing superior products to orthopedic and neurosurgeon specialists who focus on the treatment of spinal disorders and deformities through operative intervention.
ChoiceSpine is recognized for its commitment to innovation and product development, offering a comprehensive regenerative and osteobiologics portfolio. This includes synthetics, DBMs, structural allografts, and amnion allografts. The company also develops cutting-edge technologies such as its Veo™ VLIF lateral fusion system, 3D printed additive manufacturing, and the incorporation of impregnated Hydroxyapatite (HA) PEEK® interbodies. ChoiceSpine consistently aims to stay ahead of market trends and provide surgeons with dynamic solutions for their patients, improving lives and spinal surgery through innovation.
This strategic acquisition by Zavation Medical Products is expected to significantly enhance its presence and capabilities within the competitive spinal surgery market. By integrating ChoiceSpine's innovative product offerings, existing product enhancements, and continued product research and development expertise, Zavation aims to broaden its portfolio and strengthen its ability to meet the evolving needs of medical professionals. The combination of both entities is anticipated to create substantial synergies in product development, distribution networks, and overall market reach, ultimately improving the range of solutions available for spinal care.
The newly combined organization is poised to deliver an expanded suite of technically superior spinal products and dynamic solutions. This integration reinforces its commitment to advancing patient care and supporting surgeons with innovative technologies in the treatment of spinal conditions, ensuring continued progress in the field.